CD300f/LMIR3/CD300LF Antibody (234903) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2774H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunocytochemistry
Label
HRP
Antibody Source
Monoclonal Rat IgG2B Clone # 234903
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Y3 rat myeloid cell line transfected with human CD300f/LMIR3
Specificity
Detects human CD300f/LMIR3 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human LMIR1, 2, 4, 5, 6, or recombinant mouse LMIR3 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Applications for CD300f/LMIR3/CD300LF Antibody (234903) [HRP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD300f/LMIR3
Long Name
Leukocyte Mono Ig-like Receptor 3
Alternate Names
CD300f, CD300LF, CLIM1, CLM1, DIgR2, IGSF13, IREM-1, LMIR3, NKIR, Pigr3
Gene Symbol
CD300LF
Additional CD300f/LMIR3 Products
Product Documents for CD300f/LMIR3/CD300LF Antibody (234903) [HRP]
Product Specific Notices for CD300f/LMIR3/CD300LF Antibody (234903) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...